How many drugs treat Conscious sedation?

Drug Landscape tracks 5 marketed treatments for Conscious sedation (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/conscious-sedation.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Conscious sedation — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Conscious sedation (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Conscious sedation, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Precedex	dexmedetomidine	Bioxcel	Central alpha-2 Adrenergic Agonist	Alpha-1D adrenergic receptor	1999-01-01
Versed	midazolam	Generic (originally Roche)	Benzodiazepine (short-acting)	Multidrug resistance protein 1, Cytochrome P450 3A4, GABA A receptor alpha-3/beta-2/gamma-2	1985-12-20
Versed	Midazolam Hydrochloride	Takeda Pharmaceutical Company Limited	Benzodiazepine	GABA A receptor alpha-5/beta-2/gamma-2	1985-01-01
Precedex	Precedex	Helsinki University Central Hospital		Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor
Dexmedetomidin	Dexmedetomidin	Children's Hospital Medical Center, Cincinnati		Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Bioxcel · 1 drug in Conscious sedation
Children's Hospital Medical Center, Cincinnati · 1 drug in Conscious sedation
Generic (originally Roche) · 1 drug in Conscious sedation
Helsinki University Central Hospital · 1 drug in Conscious sedation
Takeda Pharmaceutical Company Limited · 1 drug in Conscious sedation

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Conscious sedation:

Cite this brief

Drug Landscape (2026). Conscious sedation — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/conscious-sedation. Accessed 2026-06-10.

Conscious sedation full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing